Literatur
-
1
Ziegler D, Hanefeld M, Ruhnau K J, Meissner H P, Lobisch M, Schutte K. et al .
Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN-study).
Diabetologica.
1995;
38
1425-1433
-
2
Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Moller W. et al .
Treamtent of diabetic polyneuropathy with the antioxidant thioctid acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
Free Radic Res.
1999;
31
171-179
-
3
Ziegler D, Hanefeld M, Ruhnau K J, Hasche H, Lobisch M, Schütte K.
Treatment of Symptomatic Diabetic Polyneuropathy With the Antioxidant Alpha-Lipoic Acid (ALADIN III Study).
Diabetes Care.
1999;
22
1296-1301
-
4
Schlotter-Weigel B, Pongratz D E.
Polyneuropathie-Therapie.
Dtsch Med Wochenschr.
2002;
127
2076-2078
Autor
Dr. Beate Schlotter-Weigel
Friedrich-Baur-Institut an der Neurologischen Klinik, Ludwig-Maximilians-Universität
Ziemssenstraße 1
80336 München
